These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

755 related items for PubMed ID: 29102649

  • 1. Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline 18F-FDG PET/CT in breast cancer with neoadjuvant chemotherapy indication.
    Garcia-Vicente AM, Pérez-Beteta J, Amo-Salas M, Molina D, Jimenez-Londoño GA, Soriano-Castrejón AM, Pena Pardo FJ, Martínez-González A.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):73-79. PubMed ID: 29102649
    [Abstract] [Full Text] [Related]

  • 2. Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate.
    Molina-García D, García-Vicente AM, Pérez-Beteta J, Amo-Salas M, Martínez-González A, Tello-Galán MJ, Soriano-Castrejón Á, Pérez-García VM.
    Ann Nucl Med; 2018 Jul; 32(6):379-388. PubMed ID: 29869770
    [Abstract] [Full Text] [Related]

  • 3. Global heterogeneity assessed with 18F-FDG PET/CT. Relation with biological variables and prognosis in locally advanced breast cancer.
    Tello Galán MJ, García Vicente AM, Pérez Beteta J, Amo Salas M, Jiménez Londoño GA, Pena Pardo FJ, Soriano Castrejón ÁM, Pérez García VM.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019 Jul; 38(5):290-297. PubMed ID: 31427247
    [Abstract] [Full Text] [Related]

  • 4. Metabolic Tumor Burden Assessed by Dual Time Point [18F]FDG PET/CT in Locally Advanced Breast Cancer: Relation with Tumor Biology.
    Garcia-Vicente AM, Pérez-Beteta J, Pérez-García VM, Molina D, Jiménez-Londoño GA, Soriano-Castrejón A, Martínez-González A.
    Mol Imaging Biol; 2017 Aug; 19(4):636-644. PubMed ID: 27981471
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with 18F-FDG PET/CT, in patients with diffuse large cell B-cell lymphoma.
    Guzmán Ortiz S, Mucientes Rasilla J, Vargas Núñez JA, Royuela A, Navarro Matilla B, Mitjavila Casanovas M.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020 Aug; 39(6):340-346. PubMed ID: 32646783
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 7. 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Metabolic Parameters Before and After Neoadjuvant Chemotherapy Can Predict the Postoperative Prognosis of Locally Advanced Gastric Cancer.
    Mi L, Zhao Y, Zhao X, Yin F, Yin X, Li N, Shi J, Han X, Duan X, Zhao M, Han G, Wang J.
    Cancer Biother Radiopharm; 2021 Oct; 36(8):662-671. PubMed ID: 32783634
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW, Oh JS, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [Abstract] [Full Text] [Related]

  • 9. Intra-tumor metabolic heterogeneity of gastric cancer on 18F-FDG PETCT indicates patient survival outcomes.
    Liu G, Yin H, Cheng X, Wang Y, Hu Y, Liu T, Shi H.
    Clin Exp Med; 2021 Feb; 21(1):129-138. PubMed ID: 32880779
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of metabolic tumour volume and total lesion glycolysis in 18F-FDG PET/CT scans in locally advanced breast cancer staging.
    Jiménez-Ballvé A, García García-Esquinas M, Salsidua-Arroyo O, Serrano-Palacio A, García-Sáenz JA, Ortega Candil A, Fuentes Ferrer ME, Rodríguez Rey C, Román-Santamaría JM, Moreno F, Carreras-Delgado JL.
    Rev Esp Med Nucl Imagen Mol; 2016 Feb; 35(6):365-372. PubMed ID: 26948652
    [Abstract] [Full Text] [Related]

  • 11. Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in 18F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy.
    Higuchi T, Fujimoto Y, Ozawa H, Bun A, Fukui R, Miyagawa Y, Imamura M, Kitajima K, Yamakado K, Miyoshi Y.
    Ann Surg Oncol; 2019 Jul; 26(7):2175-2183. PubMed ID: 30941655
    [Abstract] [Full Text] [Related]

  • 12. The correlation of 18F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer.
    Qu YH, Long N, Ran C, Sun J.
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [Abstract] [Full Text] [Related]

  • 13. Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy.
    Nakajo M, Jinguji M, Nakabeppu Y, Nakajo M, Higashi R, Fukukura Y, Sasaki K, Uchikado Y, Natsugoe S, Yoshiura T.
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
    Calles-Sastre L, Mucientes-Rasilla J, San-Frutos Llorente LM, Royuela A, Garcia-Espantaleón Navas M, Herrero Gámiz S, Pérez-Medina T.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019 Feb; 38(1):17-21. PubMed ID: 30366731
    [Abstract] [Full Text] [Related]

  • 15. Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy.
    Castello A, Toschi L, Rossi S, Finocchiaro G, Grizzi F, Mazziotti E, Qehajaj D, Rahal D, Lopci E.
    Clin Lung Cancer; 2020 Jan; 21(1):28-36. PubMed ID: 31409523
    [Abstract] [Full Text] [Related]

  • 16. 18F-FDG PET/CT quantitative parameters as prognostic factor in localized and inoperable lung cancer.
    Infante JR, Cabrera J, Rayo JI, Cruz C, Serrano J, Moreno M, Martínez A, Jiménez P, Cobo A.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020 Jan; 39(6):353-359. PubMed ID: 32605894
    [Abstract] [Full Text] [Related]

  • 17. Different 18 F-FDG PET parameters for the prediction of histological response to neoadjuvant chemotherapy in pediatric Ewing sarcoma family of tumors.
    El-Hennawy G, Moustafa H, Omar W, Elkinaai N, Kamel A, Zaki I, Farid N, El-Kholy E.
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28605. PubMed ID: 32706520
    [Abstract] [Full Text] [Related]

  • 18. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
    Im HJ, Oo S, Jung W, Jang JY, Kim SW, Cheon GJ, Kang KW, Chung JK, Kim EE, Lee DS.
    Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707
    [Abstract] [Full Text] [Related]

  • 19. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
    Wu LL, Liang JH, Wang L, Xu W, Ding CY.
    Zhonghua Zhong Liu Za Zhi; 2019 Nov 23; 41(11):831-836. PubMed ID: 31770850
    [Abstract] [Full Text] [Related]

  • 20. Prognostic utility of serial 18F-FDG-PET/CT in patients with locally advanced rectal cancer who underwent tri-modality treatment.
    Fernando S, Lin M, Pham TT, Chong S, Ip E, Wong K, Chua W, Ng W, Lin P, Lim S.
    Br J Radiol; 2020 Jan 23; 93(1105):20190455. PubMed ID: 31617737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.